All Stories

  1. Disease definitions in respiratory and sleep medicine: changes in diagnostic criteria and categories over time and clinical implications
  2. Adherence to treatment
  3. Treatment burden is important to patients but often overlooked by clinicians
  4. Systemic diseases involving the lung
  5. Models of healthcare in respiratory diseases
  6. Poor quality research and clinical practice during COVID-19
  7. Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia
  8. Screening and surveillance in respiratory medicine
  9. Biomarkers in respiratory diseases
  10. Oxygen
  11. Too much or too little medicine? Overdiagnosis, underdiagnosis, overtreatment and undertreatment in respiratory diseases
  12. Breathe: surgical interventions in pulmonary diseases
  13. Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study
  14. Screening for tuberculosis in migrants and visitors from high incidence settings: present and future perspectives
  15. Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection
  16. Performance of the LACE index to predict 30-day hospital readmissions in patients with chronic obstructive pulmonary disease
  17. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis
  18. Patient-perceived treatment burden of chronic obstructive pulmonary disease
  19. Screening strategies for active tuberculosis: focus on cost-effectiveness
  20. Benefit of treatment of latent tuberculosis infection in individual patients
  21. Benefit of treatment of latent tuberculosis infection in individual patients
  22. Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
  23. Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study
  24. Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness
  25. Biological agents and tuberculosis: risk estimates and screening strategies
  26. Correction: Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic
  27. What Patient Factors Predict Physicians’ Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?
  28. Healthcare-associated pneumonia: A US disease or relevant to the Asia Pacific, too?
  29. Risk of tuberculosis among contacts in a low-incidence setting: Table 1–
  30. What do we know about the outcomes of tuberculosis contact investigations in NSW?
  31. Letters to the Editors: Challenges in the use of tests to diagnose tuberculosis infection
  32. Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic
  33. Risk Of Tuberculosis Among Contacts In A Low Incidence Setting
  34. Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study
  35. Active case finding in contacts of people with tuberculosis
  36. Risk Of Tuberculosis Among People On Renal Replacement Therapy : A National Cohort Study
  37. Risk Of Tuberculosis Among People With Diabetes: A National Cohort Study
  38. Bronchoscopic diagnosis of endoscopically visible lung malignancies: should cytologic examinations be performed routinely?
  39. Associations between statins and COPD: a systematic review